![References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5bf0987b-81a8-4c26-bdf3-6afece0bb772/gr1_lrg.jpg)
References in Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective - The Lancet Oncology
![Computation | Free Full-Text | Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models | HTML Computation | Free Full-Text | Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models | HTML](https://www.mdpi.com/computation/computation-07-00026/article_deploy/html/images/computation-07-00026-g001.png)
Computation | Free Full-Text | Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models | HTML
![Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research - ScienceDirect Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X19304238-ga1.jpg)
Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research - ScienceDirect
![توییتر \ Arden Barry در توییتر: "The "need to know" CYP3A4 cardiac substrates and strong inducers/inhibitors from our drug interaction workshop at #CCCVan https://t.co/of9p4mJlsj" توییتر \ Arden Barry در توییتر: "The "need to know" CYP3A4 cardiac substrates and strong inducers/inhibitors from our drug interaction workshop at #CCCVan https://t.co/of9p4mJlsj"](https://pbs.twimg.com/media/DMxdXL7U8AAVNRK.jpg)
توییتر \ Arden Barry در توییتر: "The "need to know" CYP3A4 cardiac substrates and strong inducers/inhibitors from our drug interaction workshop at #CCCVan https://t.co/of9p4mJlsj"
Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches - RSC Advances (RSC Publishing)
![The commonly used substrates, inhibitors, and inducers of CYP3A4 enzyme... | Download Scientific Diagram The commonly used substrates, inhibitors, and inducers of CYP3A4 enzyme... | Download Scientific Diagram](https://www.researchgate.net/profile/Gregory-Braden/publication/233902213/figure/tbl1/AS:213458869067781@1427903968428/The-commonly-used-substrates-inhibitors-and-inducers-of-CYP3A4-enzyme-systems-top-and_Q640.jpg)
The commonly used substrates, inhibitors, and inducers of CYP3A4 enzyme... | Download Scientific Diagram
![Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole - Ishizaki - 1999 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole - Ishizaki - 1999 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a0309c4e-9e4e-4384-b6ed-6b16b6df5386/apt_022_t1.gif)
Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole - Ishizaki - 1999 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
![Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/early/2019/03/02/CJN.05180418/F2.large.jpg)
Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure | American Society of Nephrology
![Co-Administration of the CYP3A4 Inhibitor Diltiazem Counteracts Mitotane-Induced Clearance of Glucocorticoids and Antihypertensives in a Patient with Adrenocortical Carcinoma - ScienceDirect Co-Administration of the CYP3A4 Inhibitor Diltiazem Counteracts Mitotane-Induced Clearance of Glucocorticoids and Antihypertensives in a Patient with Adrenocortical Carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2376060520303825-gr3.jpg)